Osteopenia
Conditions
Interventions
Experimental group:BuShenYiJing Fang and calcium
Control group:Placebo and calcium
Sponsors
Shanghai Shuguang Hospital
Eligibility
Sex/Gender
Female
Age
55 Years to 69 Years
Inclusion criteria
Inclusion criteria: Community-dwelling women with natural menopause duration> 10 years, amenorrhea at least 12 months (T score betwean -2.0 and -2.4), 55 to 69 years of age were invited to participate in the present study.
Exclusion criteria
Exclusion criteria: We excluded women who had been diagnosed as having a neurological or musculoskeletal disorder, or coexisting chronic diseases, or long-term medications could affect results assessment, as well as the patients who have taken estrogen and calcitonin, or fluoride, bisphosphonates,adrenocortical hormone in one year could affect results assessment. Women were also excluded if one of these following abnormal lab evaluations was found: 1) alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 50% of upper normal limit; and 2) serum creatinine levels greater than 133ummol/L or 1.5 mg/dL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Femoral neck BMD;lean mass of left thigh;Timed Up and Go;number of falls; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum osteocalcin;Urine deoxypyrdinoline;Estradiol;endometrial thickness;Adverse events; | — |
Countries
China
Contacts
Public ContactShi Yinyu; Zheng Yuxin
Shanghai Shuguang Hospital
Outcome results
None listed